Corporate

Showing 15 posts of 111 posts found.

EU regulatory momentum could catalyse clinical trial innovation

June 5, 2025
Regulatory Affairs, Research and Development AI, Corporate, EU regulation, Hospital Management, Pharmacy, Veeva Systems

Dr Werner Engelbrecht at Veeva Systems discusses how compliance can be turned into a competitive advantage with connected platforms and …

handshake2

Astellas selects Veeva Vault CRM as global commercial platform

June 4, 2025
Business Services, Technical Consultancy Astrellas, Corporate, Customer Relationship Management (CRM), Pharmacy, Vault CRM, Veeva Vault CRM, business services, cloud software

Astellas has selected Veeva Vault CRM as its global customer relationship management (CRM) platform, with Veeva China CRM deployed specifically …

handshake

TQ Therapeutics acquires Juno GmbH to support decentralised cell therapy platform

May 28, 2025
Mergers and Acquisitions Cell and Gene Therapy (CGT), Corporate, Juno GmbH, TQ Therapeutics, juno therapeutics

TQ Therapeutics (TQx) has acquired Juno Therapeutics GmbH, the German subsidiary of Juno Therapeutics, through a share purchase agreement. Juno …

Orientation Marketing appoints Sarah Darcy as sales operations executive

May 27, 2025
Marketing Services, Sales and Marketing Corporate, pharmaceutical marketing agency, sales operations executive

Orientation Marketing has announced the appointment of Sarah Darcy as sales operations executive. She joins the business-to-business (B2B) life sciences and …

MC2 Therapeutics appoints Trine Ahlgreen as new CEO

May 27, 2025
Research and Development, Sales and Marketing CEO, Corporate, MC2 Therapeutics, Skin, inflammatory skin conditions

MC2 Therapeutics, a Danish pharma company focused on topical therapies for inflammatory skin conditions, has appointed Trine Ahlgreen as CEO. …

Slingshot Therapeutics appoints Ed Savory as head of chemistry

May 21, 2025
Research and Development Corporate, Pharmacy, Slingshot Therapeutics, appointment

Slingshot Therapeutics has announced the appointment of Ed Savory as head of chemistry. He will oversee the company’s chemistry strategy …

BioPhorum appoints Uwe Buecheler as non-executive director

May 21, 2025
Medical Communications, Research and Development BioPhorum, Corporate, appointment, biopharma, medical communication

BioPhorum has announced the appointment of Uwe Buecheler as a non-executive director to its board. The company brings together leaders …

Landmark BioVentures launches spin-off biotech to tackle fibrotic, neoplastic and neovascularised conditions

May 20, 2025
Research and Development Aix-Marseille University, Cardiology, Corporate, Landmark BioVentures, Massalia Therapeutics, Oncology, cardiovascular research, oncology

Landmark BioVentures and researchers at Aix-Marseille University in Marseille, France, have launched Massalia Therapeutics. Marking Landmark’s seventh company, the spin-off …

Duck Creek Technologies appoints Tyler Jones as chief marketing officer

May 20, 2025
Business Services, Pharmaceutical Consultancy Services Corporate, Duck Creek Technologies, appointment, chief marketing officer, property and casualty (P&C) insurance

Duck Creek Technologies has appointed Tyler Jones as its new chief marketing officer (CMO). He will lead the company’s global …

shaking-hands-gb7ac17374_1920

Neogap Therapeutics selected to join EIC Soft-landing Programme, supporting international growth

May 15, 2025
Medical Communications, Sales and Marketing Corporate, European Innovation Council (EIC), Immunology, Neogap Therapeutics, US pharma market, biotech, immunotherapy

Swedish biotech company, Neogap Therapeutics, has been selected to participate in the EIC Soft-landing Programme for Healthcare and Life Sciences …

handshake_2

Secarna Pharmaceuticals and Curie.Bio portfolio company enter research and option agreement

May 14, 2025
Research and Development Corporate, Cure.Bio Portfolio Company, Pharmacy, Secarna Pharmaceuticals, agreement

Global biopharma company, Secarna Pharmaceuticals, and biotech investor, Cure.Bio, have announced signing a research and option agreement, intending to accelerate …

Hansa Biopharma appoints Maria Törnsén as chief operating officer and US president

May 14, 2025
Research and Development Corporate, Hansa Biopharma, Immunology, Pharmacy, biopharma, chief operating officer (COO), immunology

Swedish biopharma company Hansa Biopharma has appointed Maria Törnsén as chief operating officer (COO) and president US effective 19 May …

Moderna expands use of AI-ready R&D platform

May 12, 2025
Business Services, Research and Development, Technical Consultancy AI, Benchling, Corporate, Moderna, R&D, digital transformation

Moderna has expanded its partnership with Benchling, a cloud-based research platform, to support its broader research organisation. Previously used by …

Apiary invests in life sciences SEO pioneer PIO to support global expansion

May 9, 2025
Agency, Business Services, Marketing Consultancies AI, Apiary Capital, Corporate, PIO, SEO, agency, investment, performance marketing, performance-io

Private equity firm Apiary Capital has invested in performance-io (PIO), a specialist life sciences performance marketing and SEO agency, to …

The Gateway to Local Adoption Series

Latest content